Skip to main content

Advertisement

Log in

Increased diagnosis and detection rates of carcinoma in situ of the breast

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The purpose of this study was to identify trends in the diagnosis of carcinoma in situ (CIS) of the breast in the United Kingdom (UK) and the Republic of Ireland (ROI) and to examine the impact of mammography. Data on cases of newly diagnosed CIS of the breast and mode of detection (screen detected or not) were obtained, where available, from regional cancer registries between 1990 and 2007. Age-standardised diagnosis rates for the UK and the ROI, and regional screen detected diagnosis rates were compared by calculating the annual percentage change (APC) over time. The APC of the diagnosis rate amongst women aged 50–64 years (original screening age group) showed a significant 5.9% increase in the UK (1990–2007) and 11.5% increase in the ROI (1994–2007). The rate of diagnosis (50–64 years) stabilized in the UK between 2005 and 2007 and was substantially higher than in other western populations with national screening programmes. The APC of the diagnosis rate amongst those aged 65–69 years showed a significant 12.4% increase in the UK (1990–2007) and 10.3% increase in the ROI (1994–2007). amongst women aged 50–74 years in the UK, approximately 4,300 cases of CIS (≈90% ductal carcinoma in situ) were diagnosed in 2007. Our analyses have shown that screen detected CIS contributed primarily to the increase in diagnosis of CIS of the breast. The high diagnosis rate of screen detected CIS of the breast underlines the need for further research into lesion and patient characteristics that are related to progression of CIS to invasive disease to better target treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Choi WS, Parker BA, Pierce JP et al (1996) Regional differences in the incidence and treatment of carcinoma in situ of the breast. Cancer Epidemiol Biomark Prev 5:317–320

    CAS  Google Scholar 

  2. Levi F, Te VC, Randimbison L et al (1997) Trends of in situ carcinoma of the breast in Vaud, Switzerland. Eur J Cancer 33:903–906

    Article  PubMed  CAS  Google Scholar 

  3. Barchielli A, Federico M, De Lisi V et al (2005) In situ breast cancer: incidence trend and organised screening programmes in Italy. Eur J Cancer 41:1045–1050

    Article  PubMed  Google Scholar 

  4. National Health Service Breast Screening Programme. Expanding our reach. Annual Review (2009) Cancer screening programmes. http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp-annualreview2009.pdf. Accessed 29 Sept 2011

  5. Kerlikowske K (2010) Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr 41:139–141

    Article  Google Scholar 

  6. Betsill WL Jr, Rosen PP, Lieberman PH et al (1978) Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. JAMA 239:1863–1867

    Article  PubMed  Google Scholar 

  7. Page DL, Dupoint WD, Rogers LW, Landenberger M (1982) Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 49:751–758

    Article  PubMed  CAS  Google Scholar 

  8. Erbas B, Provenzano E, Armes J et al (2006) The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat 97:135–144

    Article  PubMed  Google Scholar 

  9. Department of Health and Social Security (1986) Report to the Health Ministers of England, Wales, Scotland and Northern Ireland. Breast Cancer Screening. www.cancerscreening.nhs.uk/breastscreen/publications/forrest-report.pdf. Accessed 29 Sept 2011

  10. Information Services, NHS National Services Scotland. Scottish Breast Screening Programme Statistics 2007/2008 (2009) Statistical publication notice. www.isdscotland.org/isd/5974.html. Accessed 29 Sept 2011

  11. National Health Service Breast Screening Programme. Cancer Screening Programmes. www.cancerscreening.nhs.uk/breastscreen/programme-commencement.html. Accessed 29 Sept 2011

  12. Breast Test Wales. NHS Wales. http://www.screeningservices.org.uk/btw/screen/lhb.asp. Accessed 29 Sept 2011

  13. Northern Ireland Cancer Screening Programmes. HSC Public Health Agency. www.cancerscreening.n-i.nhs.uk/breast/03-C-HISTORY.html#P-4_0. Accessed 29 Sept 2011

  14. The Information Centre. http://www.ic.nhs.uk/webfiles/publications/breastscreening0607/Breast%20Screening%20Bulletin%202006-07.pdf. Accessed 29 Sept 2011

  15. Breast Test Wales. Screening Services. Breast Test Wales evidence for screening. www.screeningservices.org.uk/btw/screen/milestones.pdf. Accessed 29 Sept 2011

  16. Bennett RL, Blanks RG, Patnick J et al (2007) Results from the UK NHS Breast Screening Programme 2000–2005. J Med Screen 14:200–204

    Article  PubMed  CAS  Google Scholar 

  17. The National Breast Screening Programme. Breastcheck. Programme report 2009-2010. http://www.breastcheck.ie/publications/Programme_Report_2010.pdf. Accessed 29 Sept 2011

  18. van Steenbergen LN, Voogd AC, Roukema JA et al (2009) Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat 115:181–183

    Article  PubMed  Google Scholar 

  19. Sorum R, Hofvind S, Skaane P et al (2010) Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme. The Breast 19:499–505

    Article  PubMed  Google Scholar 

  20. Kricker A, Goumas C, Armstrong B (2004) Ductal carcinoma in situ of the breast, a population-based study of epidemiology and pathology. Br J Cancer 90:1382–1385

    Article  PubMed  CAS  Google Scholar 

  21. Barchielli A, Paci E, Giorgi D (1999) Recent trends of in situ carcinoma of the breast and mammographic screening in the Florence area, Italy. Cancer Causes Control 10:313–317

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study analysed data provided by the Eastern Cancer Registration and Information Centre (East Anglia data), Solutions for Public Health (Oxford data), South West Public Health Observatory (South Western data), Northern Ireland Cancer Registry (funded by the Public Health Agency), National Cancer Registry Ireland, West Midlands Cancer Intelligence Unit, Welsh Cancer Intelligence and Surveillance Unit and the Information Services Division, NHS National Services. JG is in receipt of a Centre for Health Improvement (Queen’s University Belfast) PhD funded scholarship.

Conflict of interest

None declared.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. A. Glover.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glover, J.A., Bannon, F.J., Hughes, C.M. et al. Increased diagnosis and detection rates of carcinoma in situ of the breast. Breast Cancer Res Treat 133, 779–784 (2012). https://doi.org/10.1007/s10549-012-1975-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-012-1975-y

Keywords

Navigation